Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $58.96 USD
Change Today +0.68 / 1.17%
Volume 1.5M
As of 8:04 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Lise Kingo

Former Chief of Staff, Executive Vice President and Member of Executive Management, Novo Nordisk A/S
AgeTotal Calculated CompensationThis person is connected to 5 board members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2013


Ms. Lise Kingo served as the Chief of Staff and Executive Vice President at Novo Nordisk A/S from March 2002 to November 24, 2014 and served as its Member of Executive Management until November 24, 2014. Ms. Kingo served as an Executive Vice President of people, reputation and relations at Novo Nordisk A/S since January 1, 2004 and as its Executive Vice President of Stakeholder Relations from March 2002 to December 2003. Ms. Kingo joined Novo Nordisk A/S’s Enzymes Promotion ...

Read Full Background

Corporate Headquarters*

Novo Allé
Bagsvaerd, Capital Region of Denmark 2880


Phone: 45 44 44 88 88
Fax: 45 44 49 05 55

Board Members Memberships*



Bachelor's Degree 1991
Copenhagen Business School
BA 1986
Aarhus Universitet
MS 2000
University of Bath

Other Affiliations*

Annual Compensation*

Total Annual Compensationkr7,000,000

Stock Options*

All Other Compensationkr2,100,000

Total Compensation*

Total Annual Cash Compensationkr9,100,000
Total Short Term Compensationkr7,000,000
Other Long Term Compensationkr2,100,000
Total Calculated Compensationkr9,100,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVO:US $58.96 USD +0.68


Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVO-NORDISK A/S-SPONS ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at